Systemic therapy of liver cancer
Author:
Publisher
Elsevier
Reference112 articles.
1. Cabozantinib in patients with advanced and progressing hepatocellular carcinoma;Abou-Alfa;The New England Journal of Medicine,2018
2. Assessment of treatment with sorafenib plus doxorubicin vs sorafenib alone in patients with advanced hepatocellular carcinoma: Phase 3 CALGB 80802 randomized clinical trial;Abou-Alfa;JAMA Oncology,2019
3. Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: Data from the fibrolamellar carcinoma consortium;Ang;Gastrointestinal Cancer Research,2013
4. Progression after immunotherapy for fibrolamellar carcinoma;Bauer;Visceral Medicine,2019
5. Interferon-alpha up-regulates the expression of PD-L1 molecules on immune cells through STAT3 and p 38 signaling;Bazhin;Frontiers in Immunology,2018
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The P53-P21-RB1 pathway promotes BRD4 degradation in liver cancer through USP1;Journal of Biological Chemistry;2024-02
2. Arenobufagin regulates the p62-Keap1-Nrf2 pathway to induce autophagy-dependent ferroptosis in HepG2 cells;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-01-02
3. hsa_circ_0002980 prevents proliferation, migration, invasion, and epithelial-mesenchymal transition of liver cancer cells through microRNA-1303/cell adhesion molecule 2 axis;Aging;2023-12-19
4. Cellular senescence-related genes: predicting prognosis in hepatocellular carcinoma;BMC Cancer;2023-10-18
5. The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma;Cancers;2023-10-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3